title: Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2.
abstract: Heat shock protein 70 is an antiapoptotic chaperone protein highly expressed in human breast tumors and tumor cell lines. Here, we demonstrate that the mere inhibition of its synthesis by adenoviral transfer or classical transfection of antisense Hsp70 cDNA (asHsp70) results in massive death of human breast cancer cells (MDA-MB-468, MCF-7, BT-549, and SK-BR-3), whereas the survival of nontumorigenic breast epithelial cells (HBL-100) or fibroblasts (WI-38) is not affected. Despite the apoptotic morphology as judged by electron microscopy, the asHsp70-induced death was independent of known caspases and the p53 tumor suppressor protein. Furthermore, Bcl-2 and Bcl-X(L), which protect tumor cells from most forms of apoptosis, failed to rescue breast cancer cells from asHsp70-induced death. These results show that tumorigenic breast cancer cells depend on the constitutive high expression of Hsp70 to suppress a transformation-associated death program. Neutralization of Hsp70 may open new possibilities for treatment of cancers that have acquired resistance to therapies activating the classical apoptosis pathway.
authors.affiliation: Apoptosis Laboratory, Danish Cancer Society, Strandboulevarden 49, Copenhagen, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Nylandsted
authors.forename: M
authors.initials: M
authors.lastname: Rohde
authors.forename: K
authors.initials: K
authors.lastname: Brand
authors.forename: L
authors.initials: L
authors.lastname: Bastholm
authors.forename: F
authors.initials: F
authors.lastname: Elling
authors.forename: M
authors.initials: M
authors.lastname: Jäättelä
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D017209:Apoptosis; D001943:Breast Neoplasms / Q000378:metabolism* / Q000628:therapy; D002277:Carcinoma / Q000378:metabolism / Q000628:therapy; D020169:Caspases / Q000378:metabolism*; D002471:Cell Transformation, Neoplastic; D018076:DNA, Complementary / Q000627:therapeutic use; D005260:Female; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D018840:HSP70 Heat-Shock Proteins / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D051020:bcl-X Protein
chemical_list: C494811:BCL2L1 protein, human; D018076:DNA, Complementary; D018840:HSP70 Heat-Shock Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D051020:bcl-X Protein; D020169:Caspases